Importance of insulin delivery devices for diabetes management

Jun 08, 2010

The growing use of insulin delivery devices such as pens and pumps may help individuals with diabetes optimize blood glucose control and minimize their risk for chronic health problems associated with diabetes, as described in a Special Supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc..

"Improved delivery devices for treatment have increased patient compliance and acceptance of an intensive insulin strategy," which can result in significant reductions in long-term complications associated with poorly controlled type 1 and type 2 diabetes, says Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver, in his Editorial entitled "Impact of Insulin Delivery Devices in Diabetes Care."

The development of automated glucose-controlled insulin infusion systems that combine the advantages of continuous glucose measurement with intravenous insulin infusion pumps "is likely to explode over the next several years," predicts Jay Skyler, MD, Professor of Medicine, Pediatrics, and Psychology at the University of Miami Miller School of Medicine (Florida), in the article, "Continuous Subcutaneous Insulin Infusion—An Historical Perspective."

Although insulin pump and pen technology have been available for quite some time, these devices are "underused, misused, or poorly used," says Irl Hirsch, MD, from the University of Washington School of Medicine (Seattle). In his Concluding Remarks, "Insulin Delivery Devices—Pumps and Pens," he reviews the reasons for the poor use of diabetes technology worldwide and predicts increased adoption of these treatment devices in the coming decade.

Eric Renard, MD, PhD, from the University of Montpellier (France), presents the factors he believes have limited insulin pump use in Europe and the need for expanded insurance coverage and education to drive increased adoption of the technology. Bruce Bode, MD, a diabetes specialist with Atlanta Diabetes Associates (Georgia), describes the promise and advantages insulin pumps offer for improving glucose control in type 2 , based on early-stage clinical research in this area.

Riccardo Perfetti, MD, PhD, from Sanofi-Aventis (Paris, France), explores the reasons for the marked geographical variation in the use of reusable and disposable insulin pens and concludes that the most important factor is likely varied access to the devices in different regions of the world. Perfetti also suggests that insulin pens have potential benefit for use in hospitalized patients, an application that has received too little attention.

Explore further: Firm recalls caramel apples amid listeria fears

More information: The issue is available free online (http://www.liebertpub.com/dia).

Provided by Mary Ann Liebert, Inc.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Firm recalls caramel apples amid listeria fears

3 hours ago

A Missouri firm is recalling its Happy Apple brand caramel apples because of the potential that they could be contaminated with listeria. The recall comes after at least three deaths and at least 29 illnesses in 10 states ...

Sierra Leone bans Christmas parties amid Ebola

17 hours ago

Alice Marke and her family aren't celebrating Christmas the way they used to: The deadly Ebola epidemic in Sierra Leone means no festive parties at the beach, no carolers singing at night.

Fourth UN staff contracts Ebola in Liberia

19 hours ago

A fourth member of the UN mission in Liberia, the country hardest-hit by the Ebola epidemic, has been hospitalised after testing positive for the virus.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.